Multiple myeloma (MM) is a challenging blood cancer characterized by the uncontrolled proliferation of abnormal plasma cells in the bone marrow. Despite advancements in treatment options, managing multiple myeloma remains complex, often requiring a multi-faceted approach. However, the advent of CD38-directed therapies has significantly changed the landscape of treatment, offering new hope and...
0 Commentarios
0 Acciones
220 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian